A. N. Holowatyj

A. N. Holowatyj is a cancer researcher at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, specializing in colorectal cancer epidemiology and molecular biomarkers. They are actively involved in the international ColoCare Study consortium, contributing to research on cancer survivorship, nutritional factors, and molecular phenotypes in colorectal cancer patients.

Dr. Holowatyj's research interests focus on the intersection of nutritional status and cancer outcomes, particularly examining how vitamin levels (such as B6) impact colorectal cancer survival. Their work also investigates molecular phenotypes in young-onset colorectal cancer through multiomics approaches and explores serum biomarkers for malignant transformation. This research bridges laboratory findings with clinical applications to improve cancer prevention and treatment strategies.

The publication record shows consistent contributions to high-impact oncology journals including The American Journal of Clinical Nutrition, Cells, and Gastroenterology. Their research demonstrates particular strength in analyzing biomarker-cancer relationships and translating these findings to clinical applications in cancer survivorship and risk assessment.

Dr. Holowatyj frequently collaborates with international researchers including Gigic, B., Ose, J., and other members of the ColoCare Study team, indicating active participation in large-scale collaborative research efforts. Their work appears to be supported through DKFZ research programs and international cancer research consortia focused on colorectal cancer epidemiology and molecular mechanisms.